{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for nonoxynol root_names_name in Any Name (approximate match)
Status:
US Approved Allergenic Extract
(2017)
Source:
BLA125592
(2017)
Source URL:
First approved in 2017
Source:
BLA125592
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125787
(2023)
Source URL:
First approved in 2023
Source:
BLA125787
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
PRLR-SLICK Cattle by Recombinetics, Inc.
(2022)
Source URL:
First approved in 2022
Source:
PRLR-SLICK Cattle by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
YorkaPig-HF-RBM20 Swine by Recombinetics, Inc.
(2020)
Source URL:
First approved in 2020
Source:
YorkaPig-HF-RBM20 Swine by Recombinetics, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125408
(2016)
Source URL:
First approved in 2016
Source:
BLA125408
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA103914
(2013)
Source URL:
First approved in 2013
Source:
BLA103914
Source URL:
Class:
STRUCTURALLY DIVERSE
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Source:
INN:velucovacap [INN]
Source URL:
Class:
G1 SPECIFIED SUBSTANCE
Status:
Other
Class:
G1 SPECIFIED SUBSTANCE
Status:
Investigational
Source:
NCT03801915: Phase 2 Interventional Completed Colon Cancer
(2019)
Source URL:
Class:
CONCEPT